Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Vera Therapeutics stock
Learn how to easily invest in Vera Therapeutics stock.
Vera Therapeutics Inc is a biotechnology business based in the US. Vera Therapeutics shares (VERA) are listed on the NASDAQ and all prices are listed in US Dollars. Vera Therapeutics employs 29 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Vera Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VERA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Vera Therapeutics stock price (NASDAQ: VERA)Use our graph to track the performance of VERA stocks over time.
Vera Therapeutics shares at a glance
|Latest market close||$21.69|
|52-week range||$12.29 - $37.11|
|50-day moving average||$19.26|
|200-day moving average||$19.52|
|Wall St. target price||$41.71|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.32|
Buy Vera Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Vera Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Vera Therapeutics price performance over time
|1 week (2022-09-22)||-0.96%|
|1 month (2022-08-29)||-0.60%|
|3 months (2022-06-29)||62.47%|
|6 months (2022-03-29)||-5.37%|
|1 year (2021-09-29)||32.01%|
|2 years (2020-09-25)||N/A|
|3 years (2019-09-25)||N/A|
|5 years (2017-09-25)||N/A|
Vera Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-28.29%|
|Return on equity TTM||-52.79%|
|Market capitalisation||$596.8 million|
TTM: trailing 12 months
Vera Therapeutics share dividends
We're not expecting Vera Therapeutics to pay a dividend over the next 12 months.
Vera Therapeutics overview
Vera Therapeutics, Inc. , a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020.
Vera Therapeutics in the news
Vera Therapeutics to Present at Upcoming Conferences in September 2022
Frequently asked questionsWhat percentage of Vera Therapeutics is owned by insiders or institutions?
Currently 8.951% of Vera Therapeutics shares are held by insiders and 92.198% by institutions. How many people work for Vera Therapeutics?
Latest data suggests 29 work at Vera Therapeutics. When does the fiscal year end for Vera Therapeutics?
Vera Therapeutics's fiscal year ends in December. Where is Vera Therapeutics based?
Vera Therapeutics's address is: 8000 Marina Boulevard, Brisbane, CA, United States, 94005 What is Vera Therapeutics's ISIN number?
Vera Therapeutics's international securities identification number is: US92337R1014 What is Vera Therapeutics's CUSIP number?
Vera Therapeutics's Committee on Uniform Securities Identification Procedures number is: 923351100
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert